■ INTRODUCTION
Binary Quantitative Structure-Activity Relationship (QSAR) analysis of results from retrospective Structure-Based Virtual Screening (SBVS) campaigns could increase the prediction quality of the SBVS protocols [1] [2] [3] [4] [5] . The use of binary QSAR in SBVS was started with the successful attempt by [2] to increase the predictive ability of SBVS protocol to identify potent ligands for estrogen receptor alpha (ERα) [6] [7] . Since then, the SBVS protocols using binary QSAR analysis incorporated in SBVS campaigns to identify marginal and potent ligands for cyclooxygenase-2 (COX-2) were developed with excellent predictive ability in retrospective studies using ligands and decoys collected by the enhanced version of Database of Useful Decoys (DUD-E) [4] [5] 7] . Notably, by employing ensemble Protein-Ligand Interaction Fingerprints (ensPLIF) as a newly introduced descriptor in binary QSAR analysis resulted from retrospective SBVS campaigns targeting ERα, the F-measure value [8] as the objective function of the predictive ability of the SBVS protocol could reach 0.769 [3] , which was significantly higher compared to the original SBVS protocol (F-measure value = 0.181) [7] . Moreover, a similar method using ensPLIF was also successfully employed in the design of lead compounds for the discovery of acetylcholinesterase inhibitors [9] .
The development of highly predictive SBVS protocols to identify ligands for ERα has started in the design of eugenol analogs as ligands for ERα [10] . Database of Useful Decoys [11] was used to 532 retrospectively validate the SBVS protocol. Inspired by [12] , PyPLIF was developed [13] and the results of the retrospective SBVS campaign [10] were employed to validate the ability of the software in increasing the predictive ability [14] . The SBVS protocol using PyPLIF [14] was subsequently employed in the discovery of novel activity for COX-2 inhibitor celecoxib as a potent ligand for ERα [15] . In 2012, DUD-E was publicly available [7] . The SBVS protocol was then re-validated [6] and combined with binary QSAR analysis using Recursive Partitioning and Regression Trees (RPART), which fortunately could significantly increase the predictive ability with an F-measure value of 0.642 [2, 16] . Moreover, the recently introduced descriptor ensPLIF in the binary QSAR could assist to reach higher predictive ability with an F-measure value of 0.769 [3] .
The potent ligands in DUD-E were defined as active ligands with affinities (IC50, EC 50 , Ki, Kd, and log variants thereof) of 1 μM or better, while active ligands with affinities above 1 μM were defined as marginal ligands [7] . Notably, there are widely known phytochemicals identified as marginal ligands for ERα [17] [18] . Unfortunately, different from COX-2 [5] , there is still no SBVS protocol to identify marginal ligands for ERα. In this article, the development of the SBVS protocol to identify marginal ligands is presented. It was started by performing SBVS campaigns on marginal ligands for ERα [7] . Together with the results from the SBVS campaigns on potent ligands for ERα and their decoys [3] , the ensPLIF values resulted from this research were employed as descriptors in the binary QSAR analysis by employing RPART method [3] . Together with the previously optimized and validated SBVS protocols to identify potent ligands for ERα [3] , the validated SBVS protocols were then incorporated in a graphical-user-interface (GUI) application. The application was then employed to virtually screen genistin, genistein, daidzin, and daidzein. The results were subsequently compared to the results from in vitro tests employing cytotoxic assay on T47D cell line using 3-[4,5dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) method [15, 19] .
■ EXPERIMENTAL SECTION

Materials
Similar to the retrospective SBVS campaigns on potent ligands for ERα [3] , the required files to perform molecular docking simulations were obtained from [10] while the required files to perform PLIF identification were obtained from [14] . Those files were plants.config, protein.mol2, water.mol2, OHT.mol2, config.txt, and ER_site.mol2. The ERα marginal ligands (marginal_ actives_nM_chembl.ism) in the SMILES format were downloaded from http://dude.docking.org/targets/esr1/. The ensPLIF values of potent ligands and decoys were obtained from [3] . Retrospective SBVS campaigns on marginal ligands for ERα were performed on a Linux (Ubuntu 12.04 LTS Precise Pangolin) machine with Intel © Xeon™ CPU E31220 (@ 3.10 GHz) as the processors and 8.00 GB of RAM using the same computational medicinal chemistry software as used by [3] : OpenBabel [20] , SPORES1.3 [21] , PLANTS1.2 [22] [23] , PyPLIF [13] [14] , and packages "rpart" [16] and "caret" [24] run inside the R computational statistics software version 3.3.0 (R-3.3.0) [25] . The development of GUI application was performed on a Linux (Linux Mint 18.3 Cinnamon 64-bit) machine with Intel © Dual Core™ i5-6200UCPU E31220 (@ 2.30 GHz) as the processors and 4.00 GB of RAM using the same software to perform SBVS campaigns appended by the following software to create a GUI application: Zenity 3.18.1.1 (http://live.gnome.org/Zenity) and BKChem 0.13.0 (http://bkchem.zirael.org/). The materials for performing the in vitro tests were the same as the materials presented in [19] . Genistein, genistin, daidzein, and daidzin as the in vitro test compounds were purchased from Sigma-Aldrich.
Procedure
The previously published procedure by [3] was adopted to perform retrospective SBVS campaigns on ERα marginal ligands [7] . There were 520 marginal ligands downloaded from http://dude.docking.org/ targets/esr1 [7] . Since there were 10 compounds shown 533 Fig 1. The decision tree adopted from the best classification tree resulted from the RPART method [3, 16] affinity values of more than 500 μM, only the remaining 510 compounds proceeded to the ligand preparation step. The results of these SBVS campaigns were then appended to the results of the SBVS campaigns of the potent ligands for ERα [3] and encoded as positives (P). The negatives (N) were obtained from the results of the SBVS campaigns of the decoys for ERα [3] . The binary QSAR models were then optimized using ensPLIF values as the descriptors [3, 9] following the same procedure as published by [3] . The EF and F-measure values were then calculated to examine the predictive quality of the protocol [3, 8] . Based on the optimized SBVS protocol to identify potent ERα ligands [3] and the optimized SBVS protocol to identify ERα marginal ligands, a GUI application was developed using BKChem to build the test compound and Zenity to display GUI dialogs of the process and the output. The developed GUI application was then employed to virtually screen genistein, genistin, daidzein, and daidzin. The in vitro test procedures were the same as the procedures employed by [19] and were performed in the Integrated Research and Assessment Laboratory, Gadjah Mada University, Yogyakarta. The IC50 values were calculated using two parameters logistic regressions in R-3.3.0 [15, [25] [26] .
■ RESULTS AND DISCUSSION
Aimed to develop SBVS protocol to identify ERα marginal ligands, retrospective SBVS campaigns on ERα marginal ligands collected by DUD-E [7] have been performed. Combined with the SBVS protocol to identify ERα potent ligands [3] , this protocol will be useful to discover phytoestrogen since, similar to COX-2, most phytochemicals active as marginal ligands for ERα [5, [17] [18] . In total, together with 20685 decoys as N [3, 7] , there were 889 active ligands as P resulted from 510 marginal ligands and 379 potent ligands [3, 7] went further in the SBVS optimization using binary QSAR to obtain the optimized decision tree [16] for the SBVS protocol. The best SBVS protocol to identify marginal ligands for ERα resulted in this research could reach EF and F-measure values of 196.759 and 0.751, respectively. These values resulted from the following confusion matrix: 575 true positives (TP), 314 false negatives (FN), 20617 true negatives (TN) and 68 false positives (FP). Based on the EF and F-measure values, the predictive ability of the SBVS protocol was considered excellent, since the values were higher than the values of the SBVS protocol to identify ligands for ERα in DUD-E (EF = 15.4; F-measure = 0.182) [7] . Moreover, no evidence for chance correlation, cross-correlation between descriptors and overfitting was found for the optimized SBVS protocol. The best decision tree incorporated in the SBVS protocol is presented in Fig. 1 .
Equipped with SBVS protocol to identify ERα marginal ligands optimized here and the published previously SBVS protocol to identify ERα potent ligands [3] , a GUI application to virtually screen a compound was developed. Similar to the availability of a GUI application to visualize molecule PyMOL to assist drug design [27] , the availability of this GUI application was expected to efficiently and effectively assist drug design and discovery particularly the ones targeting ERα. The shell scripts and other components of the GUI application following the algorithm presented in Fig. 2 could be obtained from the corresponding author or by downloading from the following link: http://esr1.molmod.org/iERa0.9.zip. Fig. 3 presents the short version of the virtual screening of genistein using the application. The full version could be found in the tutorial of the application. Refer to [20] . c) Refer to [3] . d) See Fig. 1 . The GUI application results showed that genistein and daidzein were potent ligands for ERα, while their glycosides genistin and daidzin were non-ligand for ERα. These results were in line with the in vitro experiments using MTT method on T47D cell line ( Table 1 ). The in vitro experiments employing immunochemistry method to examine the direct effects of genistein and daidzein to ERα as well as the development of a web application based on the GUI application developed here is still in progress.
■ CONCLUSION
The SBVS protocol to identify ERα marginal ligands has been optimized to have an excellent predictive ability. Together with previously published SBVS protocol to identify ERα potent ligands, this SBVS protocol was incorporated to a GUI application, which was subsequently used to virtually screen genistein, daidzein, genistin, and daidzin. The virtual screening results were confirmed by the cytotoxicity tests on T47D cell line using the MTT method. 
